Previous
Previous
Vaccine Access in the U.S. – Fall 2025 Update
Next
Next
By May, most people aren't struggling with motivation, they're struggling with consistency. The early year push has faded, schedules are full again, and the gap between intention and execution becomes clear.
At VaxPro, we think about health a little differently: not as a series of big decisions, but as the accumulation of small ones. In this article, we break down the four pillars that actually move the needle, the simple framework that makes habits stick, and the one focus we recommend for the next 30 days.
Vaccine safety evaluation continues long after approval through post-marketing surveillance systems that analyze real-world data from millions of people. Learn how monitoring tools like VAERS and the Vaccine Safety Datalink help identify rare side effects, strengthen transparency, and ensure ongoing vaccine safety.
Recently, shifts in federal vaccine advisory processes in the United States have sparked discussion across the healthcare landscape. In response, organizations such as the Massachusetts Medical Society and the Vaccine Integrity Project have announced plans to conduct independent evidence reviews of influenza, COVID-19, and RSV vaccines.